377 results on '"Luedike, Peter"'
Search Results
2. Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment
3. (Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis
4. Sex-related differences in patients presenting with heart failure–related cardiogenic shock
5. Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock
6. Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair
7. Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry
8. GLIDE Score: Scoring System for Prediction of Procedural Success in Tricuspid Valve Transcatheter Edge-to-Edge Repair
9. Mitral Valve Transcatheter Edge-to-Edge Repair: 1-Year Outcomes From the MiCLASP Study
10. BNP and NT-proBNP Thresholds for the Assessment of Prognosis in Patients Without Heart Failure
11. Septal Microsphere Embolization in Hypertrophic Obstructive Cardiomyopathy
12. Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
13. Heart failure classification based on resting ejection fraction does not display a unique exercise response pattern
14. Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
15. Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction
16. Early Outcomes of 2 Mitral Valve Transcatheter Leaflet Approximation Devices: A Propensity Score–Matched Multicenter Comparison
17. Prevalence and predictors of neurological manifestations in systemic AL amyloidosis
18. Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease
19. 18F-flutemetamol positron emission tomography in cardiac amyloidosis
20. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report
21. Predictors of functional mitral regurgitation recurrence after percutaneous mitral valve repair
22. Dual transcatheter edge-to-edge repair in a patient with cardiac amyloidosis and severe secondary mitral and tricuspid regurgitation: a case report.
23. Inflammatory and Hemolytic Responses of Microaxial Flow Pump Temporary Ventricular Assist Devices via Axillary Access in Cardiogenic Shock.
24. German Multicenter Experience With a New Leaflet-Based Transcatheter Mitral Valve Repair System for Mitral Regurgitation
25. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist
26. GLIDE Score
27. Safety and efficacy of a novel algorithm to guide decision-making in high-risk interventional coronary procedures
28. Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock
29. Mitral Valve Transcatheter Edge-to-Edge Repair:1-Year Outcomes From the MiCLASP Study
30. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis
31. A contemporary training concept in critical care cardiology
32. Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red Flags
33. Reply: Recent Evidence on Cardiac99mTc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis
34. Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis
35. Circulating macrophage migration inhibitory factor (MIF) in patients with heart failure
36. Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients
37. One‐Year Outcomes According to Mitral Regurgitation Etiology Following Transcatheter Edge‐to‐Edge Repair With the PASCAL System: Results From a Multicenter Registry
38. Clinical presentation, shock severity and mortality in patients with de novo versus acute‐on‐chronic heart failure‐related cardiogenic shock
39. Erectile dysfunction and quality of life in patients under left ventricular assist device support − an unspoken issue
40. Elevated MIF-2 levels predict mortality in critically ill patients
41. Diastolic exercise stress testing in heart failure with preserved ejection fraction: The DEST‐HF study
42. Introduction of machine perfusion of donor hearts in a single center in Germany
43. Vascular complications after peripheral veno-arterial extracorporeal life support cannulation in cardiogenic shock
44. 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis
45. MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real life cohort
46. Cardiopulmonary Profiling of Athletes with Post-Exertional Malaise after COVID-19 Infection—A Single-Center Experience
47. Increased Dead Space Ventilation as a Contributing Factor to Persistent Exercise Limitation in Patients with a Left Ventricular Assist Device
48. Moderate Continuous and Modified High-Intensity Interval Training in Patients With Left Ventricular Assist Devices: The Prospective Train-the-LVAD Trial
49. Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal Hypertrophy
50. Central extracorporeal circulatory life support (cECLS) in selected patients with critical cardiogenic shock
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.